eRAPID electronic patient self-reporting of adverse-events: patient information and advice: a pilot study protocol in pelvic radiotherapy.
Davidson, Susan E
Routledge, Jacqueline A
AffiliationDepartment of Psychology, School of Social Sciences, Leeds Beckett University, Calverley Building, Room CL 815 City Campus, Leeds, LS1 9HE UK
MetadataShow full item record
AbstractAn estimated 17,000 patients are treated annually in the UK with radical radiotherapy (RT) for pelvic cancer. New treatment approaches in RT have increased survivorship and changed the subjective toxicity profile for patients who experience acute and long-term pelvic-related adverse events (AE). Multi-disciplinary follow-up creates difficulty for monitoring and responding to these events during treatment and beyond. Originally developed for use in systemic oncology therapy eRAPID (electronic patient self-Reporting of Adverse-events: Patient Information and aDvice) is an online system for patients to report AEs from home. eRAPID enables patient data to be integrated into the electronic patient records for use in clinical practice, provides patient management advice for mild and moderate AE and advice to contact the hospital for severe AE. The system has now been developed for pelvic RT patients, and we aim to test the intervention in a pilot study with staff and patients to inform a future randomised controlled trial (RCT).
CitationeRAPID electronic patient self-reporting of adverse-events: patient information and advice: a pilot study protocol in pelvic radiotherapy. 2018, 4: 110 Pilot Feasibility Stud
JournalPilot and Feasibility Studies
- Electronic patient self-Reporting of Adverse-events: Patient Information and aDvice (eRAPID): a randomised controlled trial in systemic cancer treatment.
- Authors: Absolom K, Holch P, Warrington L, Samy F, Hulme C, Hewison J, Morris C, Bamforth L, Conner M, Brown J, Velikova G, eRAPID systemic treatment work group.
- Issue date: 2017 May 8
- Development of an integrated electronic platform for patient self-report and management of adverse events during cancer treatment.
- Authors: Holch P, Warrington L, Bamforth LCA, Keding A, Ziegler LE, Absolom K, Hector C, Harley C, Johnson O, Hall G, Morris C, Velikova G
- Issue date: 2017 Sep 1
- Online tool for monitoring adverse events in patients with cancer during treatment (eRAPID): field testing in a clinical setting.
- Authors: Warrington L, Absolom K, Holch P, Gibson A, Clayton B, Velikova G
- Issue date: 2019 Feb 1
- Phase III Randomized Controlled Trial of eRAPID: eHealth Intervention During Chemotherapy.
- Authors: Absolom K, Warrington L, Hudson E, Hewison J, Morris C, Holch P, Carter R, Gibson A, Holmes M, Clayton B, Rogers Z, McParland L, Conner M, Glidewell L, Woroncow B, Dawkins B, Dickinson S, Hulme C, Brown J, Velikova G
- Issue date: 2021 Mar 1
- Engaging Patients and Clinicians in Online Reporting of Adverse Effects During Chemotherapy for Cancer: The eRAPID System (Electronic Patient Self-Reporting of Adverse Events: Patient Information and aDvice).
- Authors: Absolom K, Gibson A, Velikova G
- Issue date: 2019 May